Together with the general lowering of the inflammation-inducing lipoproteins, among them the Lp(a) (90), an increased resolution of IL-1β-mediated vascular inflammation would allow an additional tool when attempting to reduce the risk of cardiovascular disease in people with an elevated level of Lp(a). This evidence concerns the gene LPA and inflammation.